You just read:

ACT Announces First Patients Undergo Embryonic Stem Cell Transplantation Treatment for Stargardt's Disease and Macular Degeneration at UCLA's Jules Stein Eye Institute

News provided by

Advanced Cell Technology, Inc.

Jul 14, 2011, 08:30 ET